Stock Market Today, March: CytomX Surges on Positive Data
CytomX Therapeutics delivered a sharp rally after promising Phase 1 data for its colorectal cancer program. This arti...
Compare dividend ETF charges and learn which fees apply to different ETF options, helping you understand total costs and make smarter investment choices.
21,758 articlesCytomX Therapeutics delivered a sharp rally after promising Phase 1 data for its colorectal cancer program. This arti...
Geopolitical risk around the Strait of Hormuz is flaring. This report examines which warships that could dominate Hor...
XRP sits in a tight range around $1.40 as analysts map the path to a potential break all-time high this year. The out...
A tech fund placed a sizable bet on a fresh AI chip IPO, wagering roughly $5.8 million. The stock climbed almost 200%...
Bitcoin fell to a two-week low as leveraged bets were wiped out and risk appetite faded amid geopolitical tensions an...
A synthetic covered‑call ETF on MicroStrategy stock continues to pay outs through monthly distributions, yet the stra...
As Bitcoin trades through late May 2026, Claude AI maps a bullish arc that could push BTC toward 200K by year-end. Th...
A 59-year-old with $2.4 million saved faces a six-year funding gap before Medicare. The right tax-efficient strategy ...
A cybersecurity ETF surged roughly 40% in the last month, signaling a shift in investor sentiment toward AI-enabled d...
Crypto funds see bitcoin potentially near a bottom as inflows return and risk appetite rekindles, signaling a potenti...
Global markets weigh climate risk as a likely Super El Niño could boost temperatures in 2027. This stock trader’s gui...
A tiny stock has surged 680% in a year, grabbing headlines and investor attention. This guide breaks down what’s driv...